2015
DOI: 10.1016/j.bpobgyn.2014.09.006
|View full text |Cite
|
Sign up to set email alerts
|

The first trimester: Prediction and prevention of the great obstetrical syndromes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
22
0
1

Year Published

2016
2016
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 27 publications
(24 citation statements)
references
References 111 publications
1
22
0
1
Order By: Relevance
“…Therefore, the early placenta should not be expected to release diagnostically different quantities of microRNAs into plasma until after intervillous blood flow is fully established. Attention should, therefore, be drawn to the first trimester placental bed for the purposes of risk assessment [24, 25]. However, acquiring biomarkers from the placental bed in the first trimester is invasive.…”
Section: Discussionmentioning
confidence: 99%
“…Therefore, the early placenta should not be expected to release diagnostically different quantities of microRNAs into plasma until after intervillous blood flow is fully established. Attention should, therefore, be drawn to the first trimester placental bed for the purposes of risk assessment [24, 25]. However, acquiring biomarkers from the placental bed in the first trimester is invasive.…”
Section: Discussionmentioning
confidence: 99%
“…Therefore, promising prediction models that also use more invasive measurements may have been missed. Leaving aside that studies on the added value of biomarkers to noninvasive models are scarce, the biomarkers that have been studied for the prediction of GDM show that their predictive performance is limited and contradictory results have been published [32,[37][38][39]. For future studies, we recommend to assess the added value of biomarkers only for prediction models that have been proven to perform well in external validation studies.…”
Section: Strengths and Limitationsmentioning
confidence: 99%
“…This recommendation equates GDM to the pre-diabetic state of the non-obstetric population. Subsequently, many researchers have proposed HbA1c testing in the first trimester (HbA1c-FT) as a predictor of GDM development in the third trimester [19,20], thus opening a window of opportunity for GDM prevention [21,22].…”
Section: Introductionmentioning
confidence: 99%